Clinical characteristics and short-term prognosis of in-patients with diabetes and COVID-19: A retrospective study from an academic center in Belgium
Laura Orioli, Thomas Servais, Leïla Belkhir, Pierre-François Laterre, Jean-Paul Thissen, Bernard Vandeleene, Dominique Maiter, Jean C Yombi, Michel P Hermans
Diabetes & Metabolic Syndrome: Clinical Research & Reviews, doi:10.1016/j.dsx.2020.12.020
Background and aims: We describe the characteristics and short-term prognosis of in-patients with diabetes and COVID-19 admitted to a Belgian academic care center. Methods: We retrospectively reviewed the data on admission from patients with known or newlydiagnosed diabetes and confirmed COVID-19. First, survivors were compared to non-survivors to study the predictive factors of in-hospital death in patients with diabetes. Secondly, diabetic patients with SARS-CoV-2 pneumonia were matched for age and sex with non-diabetic patients with SARS-CoV-2 pneumonia, to study the prognosis and predictive factors of in-hospital death related to diabetes. Results: Seventy-three diabetic patients were included. Mean age was 69 (±14) years. Women accounted for 52%. Most patients had type 2 diabetes (89.0%), long-term complications of hyperglycemia (59.1%), and hypertension (80.8%). The case-fatality rate (CFR) was 15%. Non-survivors had more severe pneumonia based on imaging (p 0.029) and were less often treated with metformin (p 0.036). In patients with SARS-CoV-2 pneumonia, CFR was 15.6% in diabetic (n ¼ 64) and 25.0% in non-diabetic patients (n ¼ 128), the difference being non-significant (p 0.194). Predictive factors of in-hospital death were elevated white blood cells count (HR 9.4, CI 1.50e58.8, p 0.016) and severe pneumonia on imaging (HR 25.0, CI 1.34 e466, p 0.031) in diabetic patients, and cognitive impairment (HR 5.80, CI 1.61e20.9, p 0.007) and cardiovascular disease (HR 5.63, CI 1.54e20.6, p 0.009) in non-diabetic patients. Conclusion: In this monocentric cohort from Belgium, diabetic in-patients with COVID-19 had mostly type 2 diabetes, prevalent hyperglycemia-related vascular complications and comorbidities including hypertension. In this cohort, the CFR was not statistically different between patients with and without diabetes.
References
Agarwal, Schechter, Southern, Crandall, Tomer, Preadmission diabetes-specific risk factors for mortality in hospitalized patients with diabetes and coronavirus disease 2019, Diabetes Care,
doi:10.2337/dc20-1543
Al-Salameh, Lanoix, Bennis, Andrejak, Brochot et al., Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes, Diabetes Metab Res Rev,
doi:10.1002/dmrr.3388
Barron, Bakhai, Kar, Weaver, Bradley et al., Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study, Lancet Diabetes Endocrinol,
doi:10.1016/S2213-8587(20)30272-2
Bastard, Rosen, Zhang, Michailidis, Hoffmann et al., Auto-antibodies against type I IFNs in patients with life-threatening COVID-19, Science,
doi:10.1126/science.abd4585
Bennett, Tafuro, Mayer, Darlington, Wong et al., Clinical features and outcomes of adults with COVID-19: a systematic review and pooled analysis of the literature, Int J Clin Pract,
doi:10.1111/ijcp.13725
Bramante, Ingraham, Murray, Marmor, Hoversten et al., Observational study of metformin and risk of mortality in patients hospitalized with covid-19, medRxiv,
doi:10.1101/2020.06.19.20135095
Cariou, Hadjadj, Wargny, Pichelin, Al-Salameh et al., Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study, Diabetologia,
doi:10.1007/s00125-020-05180-x
Caussy, Wallet, Laville, Disse, Obesity is associated with severe forms of COVID-19, Silver Spring,
doi:10.1002/oby.22842
Chen, Chen, Gong, Rong, Ye et al., Clinical characteristics and outcomes of type 2 diabetes patients infected with COVID-19: a retrospective study, Engineering,
doi:10.1016/j.eng.2020.05.017
Chen, Yang, Cheng, Chen, Peng et al., Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication, Diabetes Care,
doi:10.2337/dc20-0660
Crouse, Grimes, Li, Might, Ovalle et al., Metformin use is associated with reduced mortality in a diverse population with COVID-19 and diabetes, medRxiv,
doi:10.1101/2020.07.29.20164020
Dennis, Mateen, Sonabend, Thomas, Patel et al., Type 2 diabetes and COVID-19erelated mortality in the critical care setting: a national cohort study in England, marchejuly 2020, Diabetes Care,
doi:10.2337/dc20-1444
Fox, Ruddiman, Lo, Peterson, Dejoy 3rd R et al., The relationship between diabetes and clinical outcomes in COVID-19: a singlecenter retrospective analysis, Acta Diabetol,
doi:10.1007/s00592-020-01592-8
Goyal, Choi, Pinheiro, Schenck, Chen et al., Clinical characteristics of covid-19 in New York city, N Engl J Med,
doi:10.1056/NEJMc2010419
Guo, Li, Dong, Zhou, Zhang et al., Diabetes is a risk factor for the progression and prognosis of COVID-19, Diabetes Metab Res Rev,
doi:10.1002/dmrr.3319
Holman, Knighton, Kar, 'keefe, Curley et al., Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study, Lancet Diabetes Endocrinol,
doi:10.1016/S2213-8587(20)30271-0
Nachega, Ishoso, Otokoye, Hermans, Machekano et al., Clinical characteristics and outcomes of patients hospitalized for COVID-19 in Africa: early insights from the democratic republic of the Congo, Am J Trop Med Hyg,
doi:10.4269/ajtmh.20-1240
Pothen, Yildiz, Greef, Penaloza, Beauloye et al., Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: clinical experience in a Belgian tertiary center, Trav Med Infect Dis,
doi:10.1016/j.tmaid.2020.101788
Pugliese, Vitale, Resi, Orsi, Is diabetes mellitus a risk factor for Corona Virus Disease 19 (COVID-19)?, Acta Diabetol,
doi:10.1007/s00592-020-01586-6
Salinas, Blasco, Santo-Quiles, Lopez-Garrigos, Flores et al., Laboratory parameters in patients with COVID-19 on first emergency admission is different in non-survivors: albumin and lactate dehydrogenase as risk factors, J Clin Pathol,
doi:10.1136/jclinpath-2020-206865
Sciensano, Belgian institue for public health
Seiglie, Platt, Cromer, Bunda, Foulkes et al., Diabetes as a risk factor for poor early outcomes in patients hospitalized with COVID-19, Diabetes Care,
doi:10.2337/dc20-1506
Shi, Zhang, Jiang, Zhang, Hu et al., Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in wuhan, China: a two-center, retrospective study, Diabetes Care,
doi:10.2337/dc20-0598
Simonnet, Chetboun, Poissy, Raverdy, Noulette et al., High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation, Silver Spring,
doi:10.1002/oby.22831
Simpson, Kay, Abbara, Bhalla, Chung et al., Radiological society of North America expert consensus statement on reporting chest CT findings related to COVID-19. Endorsed by the society of thoracic radiology, the American college of radiology, and RSNA -secondary publication, J Thorac Imag,
doi:10.1097/RTI.0000000000000524
Singh, Gupta, Ghosh, Misra, Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations, Diabetes Metab Syndr,
doi:10.1016/j.dsx.2020.04.004
Solerte, 'addio, Trevisan, Lovati, Rossi et al., Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, casecontrol, retrospective, observational study, Diabetes Care,
doi:10.2337/dc20-1521
Vangoitsenhoven, Martens, Van Nes, Moyson, Nobels et al., Evidence of increased hospitalization rate for COVID-19 in community-dwelling patients with type 1 diabetes, Diabetes Care,
doi:10.2337/dc20-1246
Wang, Fang, Zhu, Chen, Ding et al., Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital, Clin Microbiol Infect,
doi:10.1016/j.cmi.2020.03.032
Williamson, Walker, Bhaskaran, Bacon, Bates et al., Factors associated with COVID-19-related death using OpenSAFELY, Nature,
doi:10.1038/s41586-020-2521-4
Wu, Chen, Cai, Xia, Zhou et al., Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, China, JAMA Intern Med,
doi:10.1001/jamainternmed.2020.0994
Zhang, Bastard, Liu, Pen, Velez et al., Inborn errors of type I IFN immunity in patients with life-threatening COVID-19, Science,
doi:10.1126/science.abd4570
Zheng, Peng, Xu, Zhao, Liu et al., Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis, J Infect,
doi:10.1016/j.jinf.2020.04.021